References
- Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958; 258(23):1123–1142. doi:https://doi.org/10.1056/NEJM195806052582301.
- Suzuki T, Trapnell BC. Pulmonary alveolar proteinosis syndrome. Clin Chest Med. 2016; 37(3):431–440. doi:https://doi.org/10.1016/j.ccm.2016.04.006.
- Inoue Y, Trapnell BC, Tazawa R, Japanese Center of the Rare Lung Diseases Consortium, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752–762. doi:https://doi.org/10.1164/rccm.200708-1271OC.
- Ramirez-R J, Schultz RB, Dutton RE. Pulmonary Alveolar proteinosis: A new technique and rationale for treatment. Arch Intern Med. 1963; 112(3):419–431. doi:https://doi.org/10.1001/archinte.1963.03860030173021.
- Gay P, Wallaert B, Nowak S, Groupe d''Endoscopie Thoracique de Langue Française, et al. Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF. Respiration. 2017;93(3):198–206., doi:https://doi.org/10.1159/000455179.
- Bonella F, Bauer PC, Griese M, et al. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients. Respir Med. 2011; 105(12):1908–1916. doi:https://doi.org/10.1016/j.rmed.2011.08.018.
- Zhao Y-Y, Huang H, Liu Y-Z, et al. Whole lung lavage treatment of Chinese patients with autoimmune pulmonary alveolar proteinosis: A retrospective long-term follow-up study. Chin Med J (Engl)). 2015; 128(20):2714–2719. doi:https://doi.org/10.4103/0366-6999.167295.
- Jf S, et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med. 1996; 335:1924–1925.
- Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006; 130(1):227–237. doi:https://doi.org/10.1378/chest.130.1.227.
- Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010; 181(12): 1345–1354. doi:https://doi.org/10.1164/rccm.200906-0978OC.
- Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med. 2019; 381(10):923–932. doi:https://doi.org/10.1056/NEJMoa1816216.
- Bussières J, Couture E. Whole Lung Lavage. In: Principles and Practice of Anesthesia for Thoracic Surgery. P. Slinger, Editor. 2019. Switzerland: Springer. p. 747–757.
- Campo I, Mariani F, Paracchini E, et al. Whole lung lavage followed by inhaled Sargramostim as therapy of autoimmune pulmonary alveolar ProteINOSis. Am J Respir Crit Care Med. 2016;193:A6438.
- Campo I, Kadija Z, Mariani F, et al. Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges. Multidiscip Respir Med. 2012; 7(1):4. doi:https://doi.org/10.1186/2049-6958-7-4.
- Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J. 2004; 24(3):426–435. doi:https://doi.org/10.1183/09031936.04.00076403.
- Alberti A, Luisetti M, Braschi A, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med. 1996; 154(3):817–820. doi:https://doi.org/10.1164/ajrccm.154.3.8810625.
- Gonzalez-Rothi RJ, Harris JO. Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages. Chest. 1986; 90(5):656–661. doi:https://doi.org/10.1378/chest.90.5.656.
- Hoffman RM, Dauber JH, Rogers RM. Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis. Am Rev Respir Dis. 1989; 139(4):1030–1032. doi:https://doi.org/10.1164/ajrccm/139.4.1030.
- Yamamoto H, Yamaguchi E, Agata H, et al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol. 2008; 43(8):828–830. doi:https://doi.org/10.1002/ppul.20856.
- Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med. 2002; 166(2):215–235. doi:https://doi.org/10.1164/rccm.2109105.